Dr. Reddy's Laboratories Limited (BOM:500124)
1,235.15
+18.00 (1.48%)
At close: Jan 23, 2026
Dr. Reddy's Laboratories Revenue
Dr. Reddy's Laboratories had revenue of 87.27B INR in the quarter ending December 31, 2025, with 4.40% growth. This brings the company's revenue in the last twelve months to 346.33B, up 11.06% year-over-year. In the fiscal year ending March 31, 2025, Dr. Reddy's Laboratories had annual revenue of 325.54B with 16.61% growth.
Revenue (ttm)
346.33B
Revenue Growth
+11.06%
P/S Ratio
2.93
Revenue / Employee
12.44M
Employees
27,811
Market Cap
1.01T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 325.54B | 46.37B | 16.61% |
| Mar 31, 2024 | 279.16B | 33.29B | 13.54% |
| Mar 31, 2023 | 245.88B | 31.49B | 14.69% |
| Mar 31, 2022 | 214.39B | 24.67B | 13.00% |
| Mar 31, 2021 | 189.72B | 15.12B | 8.66% |
| Mar 31, 2020 | 174.60B | 20.75B | 13.49% |
| Mar 31, 2019 | 153.85B | 11.82B | 8.32% |
| Mar 31, 2018 | 142.03B | 1.22B | 0.87% |
| Mar 31, 2017 | 140.81B | -13.90B | -8.98% |
| Mar 31, 2016 | 154.71B | 6.52B | 4.40% |
| Mar 31, 2015 | 148.19B | 16.02B | 12.12% |
| Mar 31, 2014 | 132.17B | 15.90B | 13.68% |
| Mar 31, 2013 | 116.27B | 19.53B | 20.19% |
| Mar 31, 2012 | 96.74B | 22.04B | 29.51% |
| Mar 31, 2011 | 74.69B | 4.42B | 6.28% |
| Mar 31, 2010 | 70.28B | 836.00M | 1.20% |
| Mar 31, 2009 | 69.44B | 19.44B | 38.87% |
| Mar 31, 2008 | 50.01B | -15.09B | -23.18% |
| Mar 31, 2007 | 65.10B | 40.83B | 168.24% |
| Mar 31, 2006 | 24.27B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Lupin | 247.51B |
| Torrent Pharmaceuticals | 122.48B |
| Jubilant Pharmova | 76.18B |
| Abbott India | 67.14B |
| Granules India | 48.42B |
| J. B. Chemicals & Pharmaceuticals | 41.93B |
| GlaxoSmithKline Pharmaceuticals | 37.09B |
| Caplin Point Laboratories | 20.42B |
Dr. Reddy's Laboratories News
- 5 hours ago - Stock market today: Top gainers and losers on Nifty50 and Sensex; check list - The Times of India
- 7 hours ago - Top gainers among Nifty 50 stocks in midday trades today, Jan 23: Asian Paints, Dr. Reddy’s Laboratorie, Hindustan Unilever and more - Business Upturn
- 9 hours ago - Pharma sector stocks today, Jan 23: Dr. Reddy’s Lab jumps 2.14%, Gland Pharma falls 1.71%, Torrent Pharma down 0.80% - Business Upturn
- 1 day ago - Top gainers among Nifty 50 stocks in midday trades today: Dr. Reddy’s Laboratories, Adani Enterprises, Bharat Electronics and more - Business Upturn
- 1 day ago - Dr. Reddy's (RDY) Reports Q3 Earnings with Revenue Growth - GuruFocus
- 1 day ago - Dr. Reddy's GAAP EPS of ₹14.52, revenue of ₹87.27B - Seeking Alpha
- 1 day ago - Pharma sector stocks rally today: Dr. Reddy’s Laboratories up 5%, Granules India jumps 4.33%, Strides Pharma jumps 4% - Business Upturn
- 1 day ago - Top stocks for trade today, Jan 22: Eternal, Dr Reddy’s, Shriram Finance, Bank of India, Nestlé India and more - Business Upturn